Navid Shomali
- Molecular Biology top 10%
- Oncology top 2%
- Immunology top 5%
- Cancer Research top 5%
- Biomedical Engineering top 10%
- Co-authors
- Lakshmi ThangaveluNaghmeh ShirafkanFaroogh MarofiAlexei Valerievich YumashevBehzad BaradaranWanich SuksatanAli MohammadiSupat Chupradit
- Topics
- MicroRNA in disease regulation (15 papers)CAR-T cell therapy research (15 papers)COVID-19 Clinical Research Studies (8 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- SHILAP Revista de lepidopterologíaGeneLife Sciences
In The Last Decade
Navid Shomali
77 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Biology 1.1k
- Oncology 1.0k
- Immunology 726
- Cancer Research 611
- Biomedical Engineering 267
Countries citing papers authored by Navid Shomali
This map shows the geographic impact of Navid Shomali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Shomali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Shomali more than expected).
Fields of papers citing papers by Navid Shomali
This network shows the impact of papers produced by Navid Shomali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Shomali. The network helps show where Navid Shomali may publish in the future.
Co-authorship network of co-authors of Navid Shomali
This figure shows the co-authorship network connecting the top 25 collaborators of Navid Shomali. A scholar is included among the top collaborators of Navid Shomali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Shomali. Navid Shomali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 35 | |
| 3 | 1 | |
| 4 | 17 | |
| 5 | 12 | |
| 6 | 9 | |
| 7 | Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and consbreakdown → | 306 |
| 8 | Cancer combination therapies by angiogenesis inhibitors; a comprehensive reviewbreakdown → | 129 |
| 9 | 9 | |
| 10 | 3 | |
| 11 | 12 | |
| 12 | 20 | |
| 13 | 18 | |
| 14 | 31 | |
| 15 | 6 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 12 | |
| 19 | 30 | |
| 20 | 57 |
About Navid Shomali
Navid Shomali is a scholar working on Cancer Research, Immunology and Oncology, having authored 78 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), CAR-T cell therapy research (15 papers) and COVID-19 Clinical Research Studies (8 papers). The work is most often cited by research in Cancer Research (611 citations), Oncology (1.0k citations) and Immunology (726 citations). Navid Shomali has collaborated with scholars based in Iran, Russia and Iraq. Frequent co-authors include Lakshmi Thangavelu, Naghmeh Shirafkan, Faroogh Marofi, Alexei Valerievich Yumashev, Behzad Baradaran, Wanich Suksatan, Ali Mohammadi, Supat Chupradit, Behzad Mansoori and Mostafa Jarahian. Their work appears in journals such as SHILAP Revista de lepidopterología, Gene and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.